Carson Wealth (CWM LLC)’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$6K Hold
676
﹤0.01% 2328
2021
Q1
$6K Hold
676
﹤0.01% 2327
2020
Q4
$6K Hold
676
﹤0.01% 2326
2020
Q3
$6K Hold
676
﹤0.01% 2326
2020
Q2
$6K Hold
676
﹤0.01% 2326
2020
Q1
$6K Hold
676
﹤0.01% 2326
2019
Q4
$6K Hold
676
﹤0.01% 2326
2019
Q3
$6K Hold
676
﹤0.01% 2325
2019
Q2
$6K Hold
676
﹤0.01% 2325
2019
Q1
$6K Buy
+676
New +$6.87K ﹤0.01% 2324

Other funds holding KIN

Carson Wealth (CWM LLC)'s KIN Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Kindred Biosciences, Inc. (KIN) position steady in Q2 2021 at 676 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Carson Wealth (CWM LLC) first reported a position in KIN in Q1 2019 and has held it in 10 quarters since. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • Carson Wealth (CWM LLC) held 676 shares of Kindred Biosciences, Inc. worth $6K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its Kindred Biosciences, Inc. share count unchanged in Q2 2021.
  • Kindred Biosciences, Inc. made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #2328 holding.
  • Carson Wealth (CWM LLC) first reported a position in Kindred Biosciences, Inc. in Q1 2019 and has held it in 10 quarters since.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.